Savara
SVRA
#5357
Rank
S$1.80 B
Marketcap
S$8.87
Share price
2.69%
Change (1 day)
96.94%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -S$0.16 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$0.13 Billion a decrease over its 2023 earnings that were of -S$70.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.16 Billion22.74%
2024 -S$0.13 Billion75.29%
2023 -S$70.67 Million43.38%
2022 -S$49.29 Million-11.31%
2021 -S$55.57 Million-13.3%
2020 -S$64.1 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$88.78 Million105.54%
2017 -S$43.2 Million34.11%
2016 -S$32.21 Million-37.43%
2015 -S$51.47 Million38.81%
2014 -S$37.08 Million33.62%
2013 -S$27.75 Million38.49%
2012 -S$20.04 Million24.59%
2011 -S$16.09 Million-36.5%
2010 -S$25.33 Million-3.14%
2009 -S$26.15 Million-23.28%
2008 -S$34.09 Million8.52%
2007 -S$31.41 Million-34.14%
2006 -S$47.69 Million184.43%
2005 -S$16.77 Million90.75%
2004 -S$8.79 Million190.35%
2003 -S$3.03 Million11.64%
2002 -S$2.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-S$23.46 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-S$0.21 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA